LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Education
• Health & Fitness
• Insurance

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,625,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

article, patients, bms, pubmed, roche, melanoma, msd, ipilimumab, google, scholar, novartis, cancer, amgen, germany, department, dermatology, university, received, metastatic, preexisting, serves, cas, travel, grants, autoimmune, kähler, gutzmer, speaker, adverse, gsk, eigentler, heinzerling, events, central, katharina, gesierich, loquai, zimmer, treatment, center, therapy, oncol, hospital, fees, immunotherapy, disorders, meier, treated, hassel, clin,

Topics {✒️}

anti-cytotoxic t-lymphocyte antigen-4 month download article/chapter anti-pd-1 antibody therapy high-grade adverse events gov/ftp1/ctcae/ctcae_4 pre-existing autoimmune disorders anti-ctla-4 antibody ipilimumab pre-existing ad treated article cancer immunology university hospital schleswig-holstein anti-pd-1 therapy related subjects anti-ctla-4 therapy full article pdf prognostic factors related 44 pre-existing ad pre-existing ad received research grants privacy choices/manage cookies pd-1 antibody pembrolizumab preexisting autoimmune disorders german cancer consortium skin cancer center hannover medical school university medical center dermatologic diseases ipilimumab-triggered autoimmunity systemic autoimmune disease european economic area rare side effects active ulcerative colitis revised recist guideline ocular side-effects randomized phase ii rosalind-franklind-str share collective responsibility bristol-myers squibb eberhard-karls university received travel grants ralf gutzmer planned conditions privacy policy metastatic melanoma treated disease/ulcerative colitis mihm mc jr ralf gutzmer contributed check access response evaluation criteria instant access eigentler tk adverse events

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders
         description:Ipilimumab and programmed death (PD) 1-antibodies are effective treatment options in metastatic melanoma. The safety and efficacy of ipilimumab in patients with pre-existing autoimmune disorders (AD) has only been evaluated in a selected number of patients. We performed a retrospective analysis in 14 German skin cancer centers for patients with metastatic melanoma and pre-existing AD treated with ipilimumab. 41 patients with 44 pre-existing AD were treated with ipilimumab (thyroiditis n = 15, rheumatoid n = 11, dermatologic n = 10, Crohn’s disease/ulcerative colitis n = 3, neurological n = 2, sarcoidosis n = 2, pancreatitis n = 1). 3 out of 41 patients had two AD, 11 patients required immunosuppressants at the time of induction of ipilimumab. 12 patients (29.2%) experienced a flare of their pre-existing AD, mainly patients with rheumatoid or dermatologic diseases. Additional immune-related adverse events (irAEs) occurred in 12 patients (29.2%). In 23 patients (56%) neither a change of their AD nor additional irAEs were observed. Objective responses were seen in five patients (one complete remission, four partial remissions, 12.1%). This is the largest series of patients with pre-existing AD and treatment with ipilimumab reported. Flares of pre-existing AD were observed but manageable. Response rates and occurrence of new irAEs were comparable to previous trials. Thus, in this patient subgroup, ipilimumab can be a treatment option after a thorough discussion of pros and cons and taking severity and activity of the preexisting AD into account.
         datePublished:2018-02-27T00:00:00Z
         dateModified:2018-02-27T00:00:00Z
         pageStart:825
         pageEnd:834
         sameAs:https://doi.org/10.1007/s00262-018-2134-z
         keywords:
            Ipilimumab
            Melanoma
            Immune-related adverse events
            Autoimmunity
            Oncology
            Immunology
            Cancer Research
         image:
         isPartOf:
            name:Cancer Immunology, Immunotherapy
            issn:
               1432-0851
               0340-7004
            volumeNumber:67
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Katharina C. Kähler
               affiliation:
                     name:University Hospital Schleswig-Holstein (UKSH)
                     address:
                        name:Department of Dermatology, Campus Kiel, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Thomas K. Eigentler
               affiliation:
                     name:Eberhard-Karls University of Tübingen
                     address:
                        name:Department of Dermatology, Eberhard-Karls University of Tübingen, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anja Gesierich
               affiliation:
                     name:University Hospital Würzburg
                     address:
                        name:Department of Dermatology, University Hospital Würzburg, Würzburg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lucie Heinzerling
               affiliation:
                     name:University Hospital Erlangen
                     address:
                        name:Department of Dermatology, University Hospital Erlangen, Erlangen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Carmen Loquai
               affiliation:
                     name:University Medical Center of Mainz
                     address:
                        name:Department of Dermatology, University Medical Center of Mainz, Mainz, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Friedegund Meier
               affiliation:
                     name:University of Dresden
                     address:
                        name:Department of Dermatology, University of Dresden, Dresden, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Frank Meiss
               affiliation:
                     name:University of Freiburg
                     address:
                        name:Department of Dermatology, Medical Center - Faculty of Medicine, University of Freiburg, Freiburg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Claudia Pföhler
               affiliation:
                     name:Saarland University Medical School
                     address:
                        name:Department of Dermatology, Saarland University Medical School, Homburg/saar, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Max Schlaak
               affiliation:
                     name:University Hospital Cologne
                     address:
                        name:Department of Dermatology, Skin Cancer Center at Center of Integrated Oncology (CIO), University Hospital Cologne, Cologne-Bonn, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Patrick Terheyden
               affiliation:
                     name:Campus LübeckUniversity, Hospital (UKSH)
                     address:
                        name:Department of Dermatology, Campus LübeckUniversity, Hospital (UKSH), Lübeck, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kai M. Thoms
               affiliation:
                     name:University Medical Center Göttingen
                     address:
                        name:Department of Dermatology, University Medical Center Göttingen, Göttingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mirjana Ziemer
               affiliation:
                     name:University Hospital Leipzig
                     address:
                        name:Department of Dermatology, University Hospital Leipzig, Leipzig, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lisa Zimmer
               affiliation:
                     name:University Duisburg-Essen, University Hospital Essen
                     address:
                        name:Department of Dermatology, Essen, Germany and German Cancer Consortium (DKTK), University Duisburg-Essen, University Hospital Essen, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ralf Gutzmer
               affiliation:
                     name:Hannover Medical School
                     address:
                        name:Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hanover, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders
      description:Ipilimumab and programmed death (PD) 1-antibodies are effective treatment options in metastatic melanoma. The safety and efficacy of ipilimumab in patients with pre-existing autoimmune disorders (AD) has only been evaluated in a selected number of patients. We performed a retrospective analysis in 14 German skin cancer centers for patients with metastatic melanoma and pre-existing AD treated with ipilimumab. 41 patients with 44 pre-existing AD were treated with ipilimumab (thyroiditis n = 15, rheumatoid n = 11, dermatologic n = 10, Crohn’s disease/ulcerative colitis n = 3, neurological n = 2, sarcoidosis n = 2, pancreatitis n = 1). 3 out of 41 patients had two AD, 11 patients required immunosuppressants at the time of induction of ipilimumab. 12 patients (29.2%) experienced a flare of their pre-existing AD, mainly patients with rheumatoid or dermatologic diseases. Additional immune-related adverse events (irAEs) occurred in 12 patients (29.2%). In 23 patients (56%) neither a change of their AD nor additional irAEs were observed. Objective responses were seen in five patients (one complete remission, four partial remissions, 12.1%). This is the largest series of patients with pre-existing AD and treatment with ipilimumab reported. Flares of pre-existing AD were observed but manageable. Response rates and occurrence of new irAEs were comparable to previous trials. Thus, in this patient subgroup, ipilimumab can be a treatment option after a thorough discussion of pros and cons and taking severity and activity of the preexisting AD into account.
      datePublished:2018-02-27T00:00:00Z
      dateModified:2018-02-27T00:00:00Z
      pageStart:825
      pageEnd:834
      sameAs:https://doi.org/10.1007/s00262-018-2134-z
      keywords:
         Ipilimumab
         Melanoma
         Immune-related adverse events
         Autoimmunity
         Oncology
         Immunology
         Cancer Research
      image:
      isPartOf:
         name:Cancer Immunology, Immunotherapy
         issn:
            1432-0851
            0340-7004
         volumeNumber:67
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Katharina C. Kähler
            affiliation:
                  name:University Hospital Schleswig-Holstein (UKSH)
                  address:
                     name:Department of Dermatology, Campus Kiel, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Thomas K. Eigentler
            affiliation:
                  name:Eberhard-Karls University of Tübingen
                  address:
                     name:Department of Dermatology, Eberhard-Karls University of Tübingen, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anja Gesierich
            affiliation:
                  name:University Hospital Würzburg
                  address:
                     name:Department of Dermatology, University Hospital Würzburg, Würzburg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lucie Heinzerling
            affiliation:
                  name:University Hospital Erlangen
                  address:
                     name:Department of Dermatology, University Hospital Erlangen, Erlangen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Carmen Loquai
            affiliation:
                  name:University Medical Center of Mainz
                  address:
                     name:Department of Dermatology, University Medical Center of Mainz, Mainz, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Friedegund Meier
            affiliation:
                  name:University of Dresden
                  address:
                     name:Department of Dermatology, University of Dresden, Dresden, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Frank Meiss
            affiliation:
                  name:University of Freiburg
                  address:
                     name:Department of Dermatology, Medical Center - Faculty of Medicine, University of Freiburg, Freiburg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Claudia Pföhler
            affiliation:
                  name:Saarland University Medical School
                  address:
                     name:Department of Dermatology, Saarland University Medical School, Homburg/saar, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Max Schlaak
            affiliation:
                  name:University Hospital Cologne
                  address:
                     name:Department of Dermatology, Skin Cancer Center at Center of Integrated Oncology (CIO), University Hospital Cologne, Cologne-Bonn, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Patrick Terheyden
            affiliation:
                  name:Campus LübeckUniversity, Hospital (UKSH)
                  address:
                     name:Department of Dermatology, Campus LübeckUniversity, Hospital (UKSH), Lübeck, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kai M. Thoms
            affiliation:
                  name:University Medical Center Göttingen
                  address:
                     name:Department of Dermatology, University Medical Center Göttingen, Göttingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mirjana Ziemer
            affiliation:
                  name:University Hospital Leipzig
                  address:
                     name:Department of Dermatology, University Hospital Leipzig, Leipzig, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lisa Zimmer
            affiliation:
                  name:University Duisburg-Essen, University Hospital Essen
                  address:
                     name:Department of Dermatology, Essen, Germany and German Cancer Consortium (DKTK), University Duisburg-Essen, University Hospital Essen, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ralf Gutzmer
            affiliation:
                  name:Hannover Medical School
                  address:
                     name:Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hanover, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Immunology, Immunotherapy
      issn:
         1432-0851
         0340-7004
      volumeNumber:67
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University Hospital Schleswig-Holstein (UKSH)
      address:
         name:Department of Dermatology, Campus Kiel, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany
         type:PostalAddress
      name:Eberhard-Karls University of Tübingen
      address:
         name:Department of Dermatology, Eberhard-Karls University of Tübingen, Tübingen, Germany
         type:PostalAddress
      name:University Hospital Würzburg
      address:
         name:Department of Dermatology, University Hospital Würzburg, Würzburg, Germany
         type:PostalAddress
      name:University Hospital Erlangen
      address:
         name:Department of Dermatology, University Hospital Erlangen, Erlangen, Germany
         type:PostalAddress
      name:University Medical Center of Mainz
      address:
         name:Department of Dermatology, University Medical Center of Mainz, Mainz, Germany
         type:PostalAddress
      name:University of Dresden
      address:
         name:Department of Dermatology, University of Dresden, Dresden, Germany
         type:PostalAddress
      name:University of Freiburg
      address:
         name:Department of Dermatology, Medical Center - Faculty of Medicine, University of Freiburg, Freiburg, Germany
         type:PostalAddress
      name:Saarland University Medical School
      address:
         name:Department of Dermatology, Saarland University Medical School, Homburg/saar, Germany
         type:PostalAddress
      name:University Hospital Cologne
      address:
         name:Department of Dermatology, Skin Cancer Center at Center of Integrated Oncology (CIO), University Hospital Cologne, Cologne-Bonn, Germany
         type:PostalAddress
      name:Campus LübeckUniversity, Hospital (UKSH)
      address:
         name:Department of Dermatology, Campus LübeckUniversity, Hospital (UKSH), Lübeck, Germany
         type:PostalAddress
      name:University Medical Center Göttingen
      address:
         name:Department of Dermatology, University Medical Center Göttingen, Göttingen, Germany
         type:PostalAddress
      name:University Hospital Leipzig
      address:
         name:Department of Dermatology, University Hospital Leipzig, Leipzig, Germany
         type:PostalAddress
      name:University Duisburg-Essen, University Hospital Essen
      address:
         name:Department of Dermatology, Essen, Germany and German Cancer Consortium (DKTK), University Duisburg-Essen, University Hospital Essen, Heidelberg, Germany
         type:PostalAddress
      name:Hannover Medical School
      address:
         name:Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hanover, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Katharina C. Kähler
      affiliation:
            name:University Hospital Schleswig-Holstein (UKSH)
            address:
               name:Department of Dermatology, Campus Kiel, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Thomas K. Eigentler
      affiliation:
            name:Eberhard-Karls University of Tübingen
            address:
               name:Department of Dermatology, Eberhard-Karls University of Tübingen, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:Anja Gesierich
      affiliation:
            name:University Hospital Würzburg
            address:
               name:Department of Dermatology, University Hospital Würzburg, Würzburg, Germany
               type:PostalAddress
            type:Organization
      name:Lucie Heinzerling
      affiliation:
            name:University Hospital Erlangen
            address:
               name:Department of Dermatology, University Hospital Erlangen, Erlangen, Germany
               type:PostalAddress
            type:Organization
      name:Carmen Loquai
      affiliation:
            name:University Medical Center of Mainz
            address:
               name:Department of Dermatology, University Medical Center of Mainz, Mainz, Germany
               type:PostalAddress
            type:Organization
      name:Friedegund Meier
      affiliation:
            name:University of Dresden
            address:
               name:Department of Dermatology, University of Dresden, Dresden, Germany
               type:PostalAddress
            type:Organization
      name:Frank Meiss
      affiliation:
            name:University of Freiburg
            address:
               name:Department of Dermatology, Medical Center - Faculty of Medicine, University of Freiburg, Freiburg, Germany
               type:PostalAddress
            type:Organization
      name:Claudia Pföhler
      affiliation:
            name:Saarland University Medical School
            address:
               name:Department of Dermatology, Saarland University Medical School, Homburg/saar, Germany
               type:PostalAddress
            type:Organization
      name:Max Schlaak
      affiliation:
            name:University Hospital Cologne
            address:
               name:Department of Dermatology, Skin Cancer Center at Center of Integrated Oncology (CIO), University Hospital Cologne, Cologne-Bonn, Germany
               type:PostalAddress
            type:Organization
      name:Patrick Terheyden
      affiliation:
            name:Campus LübeckUniversity, Hospital (UKSH)
            address:
               name:Department of Dermatology, Campus LübeckUniversity, Hospital (UKSH), Lübeck, Germany
               type:PostalAddress
            type:Organization
      name:Kai M. Thoms
      affiliation:
            name:University Medical Center Göttingen
            address:
               name:Department of Dermatology, University Medical Center Göttingen, Göttingen, Germany
               type:PostalAddress
            type:Organization
      name:Mirjana Ziemer
      affiliation:
            name:University Hospital Leipzig
            address:
               name:Department of Dermatology, University Hospital Leipzig, Leipzig, Germany
               type:PostalAddress
            type:Organization
      name:Lisa Zimmer
      affiliation:
            name:University Duisburg-Essen, University Hospital Essen
            address:
               name:Department of Dermatology, Essen, Germany and German Cancer Consortium (DKTK), University Duisburg-Essen, University Hospital Essen, Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Ralf Gutzmer
      affiliation:
            name:Hannover Medical School
            address:
               name:Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hanover, Germany
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Dermatology, Campus Kiel, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany
      name:Department of Dermatology, Eberhard-Karls University of Tübingen, Tübingen, Germany
      name:Department of Dermatology, University Hospital Würzburg, Würzburg, Germany
      name:Department of Dermatology, University Hospital Erlangen, Erlangen, Germany
      name:Department of Dermatology, University Medical Center of Mainz, Mainz, Germany
      name:Department of Dermatology, University of Dresden, Dresden, Germany
      name:Department of Dermatology, Medical Center - Faculty of Medicine, University of Freiburg, Freiburg, Germany
      name:Department of Dermatology, Saarland University Medical School, Homburg/saar, Germany
      name:Department of Dermatology, Skin Cancer Center at Center of Integrated Oncology (CIO), University Hospital Cologne, Cologne-Bonn, Germany
      name:Department of Dermatology, Campus LübeckUniversity, Hospital (UKSH), Lübeck, Germany
      name:Department of Dermatology, University Medical Center Göttingen, Göttingen, Germany
      name:Department of Dermatology, University Hospital Leipzig, Leipzig, Germany
      name:Department of Dermatology, Essen, Germany and German Cancer Consortium (DKTK), University Duisburg-Essen, University Hospital Essen, Heidelberg, Germany
      name:Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hanover, Germany
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(113)

• Check the income stats for https://www.springernature.com/gp/authors
• How much profit is https://link.springernature.com/home/ making per month?
• How much does https://order.springer.com/public/cart net monthly?
• Learn how profitable https://submission.nature.com/new-submission/262/3 is on a monthly basis
• Check the income stats for https://www.springernature.com/gp/librarians/licensing/agc/journals
• https://doi.org/10.1016%2Fj.jval.2016.03.1631's total income per month
• How much income is http://scholar.google.com/scholar_lookup?&title=Prevalence%20of%20autoimmune%20comorbidities%20in%20patients%20with%20metastatic%20melanoma%20in%20the%20US&journal=Value%20Health&doi=10.1016%2Fj.jval.2016.03.1631&volume=19&issue=3&publication_year=2018&author=Ma%2CQ&author=Shilkrut%2CM&author=Li%2CM&author=Barber%2CBL&author=Zhao%2CZ earning monthly?
• Explore the financials of https://doi.org/10.1001%2Fjamaoncol.2015.4368
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26633184 produce monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Ipilimumab%20therapy%20in%20patients%20with%20advanced%20melanoma%20and%20preexisting%20autoimmune%20disorders&journal=JAMA%20Oncol&doi=10.1001%2Fjamaoncol.2015.4368&volume=2&pages=234-240&publication_year=2016&author=Johnson%2CDB&author=Sullivan%2CRJ&author=Ott%2CPA&author=Carlino%2CMS4&author=Khushalani%2CNI&author=Ye%2CF&author=Guminski%2CA&author=Puzanov%2CI&author=Lawrence%2CDP&author=Buchbinder%2CE&author=Mudigonda%2CT&author=Spencer%2CK&author=Bender%2CC&author=Lee%2CJ&author=Kaufman%2CHL&author=Menzies%2CAM&author=Hassel%2CJC&author=Mehnert%2CJM&author=Sosman%2CJA&author=Long%2CGV&author=Clark%2CJI make?
• What's the financial outcome of https://doi.org/10.1093%2Fannonc%2Fmdx377.007?
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27687304
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Anti-PD-1%20therapy%20in%20patients%20with%20advanced%20melanoma%20and%20preexisting%20autoimmune%20disorders%20or%20major%20toxicity%20with%20ipilimumab&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdx377.007&volume=28&pages=368-376&publication_year=2017&author=Menzies%2CAM&author=Johnson%2CDB&author=Ramanujam%2CS&author=Atkinson%2CVG&author=Wong%2CAN&author=Park%2CJJ&author=McQuade%2CJL&author=Shoushtari%2CAN&author=Tsai%2CKK&author=Eroglu%2CZ&author=Klein%2CO&author=Hassel%2CJC&author=Sosman%2CJA&author=Guminski%2CA&author=Sullivan%2CRJ&author=Ribas%2CA&author=Carlino%2CMS&author=Davies%2CMA&author=Sandhu%2CSK&author=Long%2CGV produce monthly?
• Get to know https://doi.org/10.1016%2Fj.ejca.2016.12.038's earnings
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28214654's financial summary
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Programmed%20cell%20death%20protein-1%20%28PD-1%29%20inhibitor%20therapy%20in%20patients%20with%20advanced%20melanoma%20and%20preexisting%20autoimmunity%20or%20ipilimumab-triggered%20autoimmunity&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2016.12.038&volume=75&pages=24-32&publication_year=2017&author=Gutzmer%2CR&author=Koop%2CA&author=Meier%2CF&author=Hassel%2CJC&author=Terheyden%2CP&author=Zimmer%2CL&author=Heinzerling%2CL&author=Ugurel%2CS&author=Pf%C3%B6hler%2CC&author=Gesierich%2CA&author=Livingstone%2CE&author=Satzger%2CI&author=K%C3%A4hler%2CKC
• What's the financial outcome of https://doi.org/10.1371%2Fjournal.pone.0053745?
• Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23341990
• What's the financial intake of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544906?
• How much profit does http://scholar.google.com/scholar_lookup?&title=The%20price%20of%20tumor%20control%3A%20an%20analysis%20of%20rare%20side%20effects%20of%20anti-CTLA-4%20therapy%20in%20metastatic%20melanoma%20from%20the%20ipilimumab%20network&journal=PLoS%20One&doi=10.1371%2Fjournal.pone.0053745&volume=8&publication_year=2013&author=Voskens%2CCJ&author=Goldinger%2CSM&author=Loquai%2CC&author=Robert%2CC&author=Kaehler%2CKC&author=Berking%2CC&author=Bergmann%2CT&author=Bockmeyer%2CCL&author=Eigentler%2CT&author=Fluck%2CM&author=Garbe%2CC&author=Gutzmer%2CR&author=Grabbe%2CS&author=Hauschild%2CA&author=Hein%2CR&author=Hundorfean%2CG&author=Justich%2CA&author=Keller%2CU&author=Klein%2CC&author=Mateus%2CC&author=Mohr%2CP&author=Paetzold%2CS&author=Satzger%2CI&author=Schadendorf%2CD&author=Schlaeppi%2CM&author=Schuler%2CG&author=Schuler-Thurner%2CB&author=Trefzer%2CU&author=Ulrich%2CJ&author=Vaubel%2CJ&author=Moos%2CR&author=Weder%2CP&author=Wilhelm%2CT&author=G%C3%B6ppner%2CD&author=Dummer%2CR&author=Heinzerling%2CLM make?
• What's the financial intake of https://doi.org/10.1016%2Fj.ctrv.2016.02.003?
• How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26922661 have?
• Get to know http://scholar.google.com/scholar_lookup?&title=Diagnosis%2C%20monitoring%20and%20management%20of%20immune-related%20adverse%20drug%20reactions%20of%20anti-PD-1%20antibody%20therapy&journal=Cancer%20Treat%20Rev&doi=10.1016%2Fj.ctrv.2016.02.003&volume=45&pages=7-18&publication_year=2016&author=Eigentler%2CTK&author=Hassel%2CJC&author=Berking%2CC&author=Aberle%2CJ&author=Bachmann%2CO&author=Gr%C3%BCnwald%2CV&author=K%C3%A4hler%2CKC&author=Loquai%2CC&author=Reinmuth%2CN&author=Steins%2CM&author=Zimmer%2CL&author=Sendl%2CA&author=Gutzmer%2CR's earnings
• How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25349698?
• How much cash flow does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207313 have monthly?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Ipilimumab%20in%20patients%20with%20melanoma%20and%20autoimmune%20disease&journal=J%20Immunother%20Cancer&doi=10.1186%2Fs40425-014-0035-z&volume=2&publication_year=2014&author=Kyi%2CC&author=Carvajal%2CRD&author=Wolchok%2CJD&author=Postow%2CMA
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25992290?
• How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437559 net monthly?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Rapid%20complete%20response%20of%20metastatic%20melanoma%20in%20a%20patient%20undergoing%20ipilimumab%20immunotherapy%20in%20the%20setting%20of%20active%20ulcerative%20colitis&journal=J%20Immunother%20Cancer&doi=10.1186%2Fs40425-015-0064-2&volume=3&publication_year=2015&author=Bostwick%2CAD&author=Salama%2CAK&author=Hanks%2CBA bring in?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25227926 make?
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Successful%20treatment%20with%20Ipilimumab%20and%20Interleukin-2%20in%20two%20patients%20with%20metastatic%20melanoma%20and%20systemic%20autoimmune%20disease&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-014-1607-y&volume=63&pages=1341-1346&publication_year=2014&author=Pedersen%2CM&author=Andersen%2CR&author=N%C3%B8rgaard%2CP&author=Jacobsen%2CS&author=Thielsen%2CP&author=Thor%20Straten%2CP&author=Svane%2CIM?
• Get to know https://doi.org/10.1200%2FJCO.2009.23.4799's earnings
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Final%20version%20of%202009%20AJCC%20melanoma%20staging%20and%20classification&journal=J%20of%20Clin%20Oncology&doi=10.1200%2FJCO.2009.23.4799&volume=27&pages=6199-6206&publication_year=2009&author=Balch%2CCM&author=Gershenwald%2CJE&author=Soong%2CSJ&author=Thompson%2CJF&author=Atkins%2CMB&author=Byrd%2CDR&author=Buzaid%2CAC&author=Cochran%2CAJ&author=Coit%2CDG&author=Ding%2CS&author=Eggermont%2CAM&author=Flaherty%2CKT&author=Gimotty%2CPA&author=Kirkwood%2CJM&author=McMasters%2CKM&author=Mihm%2CMC&author=Morton%2CDL&author=Ross%2CMI&author=Sober%2CAJ&author=Sondak%2CVK?
• How much profit does https://doi.org/10.1016%2Fj.ejca.2008.10.026 generate?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19097774 produce monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=New%20response%20evaluation%20criteria%20in%20solid%20tumours%3A%20revised%20RECIST%20guideline%20%28version%201.1%29&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2008.10.026&volume=45&pages=228-247&publication_year=2009&author=Eisenhauer%2CEA&author=Therasse%2CP&author=Bogaerts%2CJ&author=Schwartz%2CLH&author=Sargent%2CD&author=Ford%2CR&author=Dancey%2CJ&author=Arbuck%2CS&author=Gwyther%2CS&author=Mooney%2CM&author=Rubinstein%2CL&author=Shankar%2CL&author=Dodd%2CL&author=Kaplan%2CR&author=Lacombe%2CD&author=Verweij%2CJ net monthly?
• How much profit does https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf generate?
• How much profit is https://doi.org/10.1093%2Fannonc%2Fmdw128 making per month?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26951629 earn?
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Safety%20of%20the%20PD-1%20antibody%20pembrolizumab%20in%20patients%20with%20high-grade%20adverse%20events%20under%20ipilimumab%20treatment&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdw128&volume=27&pages=1353-1354&publication_year=2016&author=Bender%2CC&author=Dimitrakopoulou-Strauss%2CA&author=Enk%2CA&author=Hassel%2CJC
• How much does http://scholar.google.com/scholar_lookup?&title=Central%20nervous%20system%20toxicities%20of%20anti-cancer%20immune%20checkpoint%20blockade&journal=J%20Neurol%20Neuromed&volume=4&pages=39-45&publication_year=2016&author=Blackmon%2CJT&author=Viator%2CTM&author=Conry%2CRM gross monthly?
• How much revenue does https://doi.org/10.1016%2Fj.ejca.2016.02.024 produce monthly?
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27084345?
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Neurological%2C%20respiratory%2C%20musculoskeletal%2C%20cardiac%20and%20ocular%20side-effects%20of%20anti-PD-1%20therapy&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2016.02.024&volume=60&pages=210-225&publication_year=2016&author=Zimmer%2CL&author=Goldinger%2CSM&author=Hofmann%2CL&author=Loquai%2CC&author=Ugurel%2CS&author=Thomas%2CI&author=Schmidgen%2CMI&author=Gutzmer%2CR&author=Utikal%2CJS&author=G%C3%B6ppner%2CD&author=Hassel%2CJC&author=Meier%2CF&author=Tietze%2CJK&author=Forschner%2CA&author=Weishaupt%2CC&author=Leverkus%2CM&author=Wahl%2CR&author=Dietrich%2CU&author=Garbe%2CC&author=Kirchberger%2CMC&author=Eigentler%2CT&author=Berking%2CC&author=Gesierich%2CA&author=Krackhardt%2CAM&author=Schadendorf%2CD&author=Schuler%2CG&author=Dummer%2CR&author=Heinzerling%2CLM is on a monthly basis
• Explore the financials of https://doi.org/10.1200%2FJCO.2017.73.2289
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28841387 bring in each month?
• How much cash flow does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791828 have monthly?
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Efficacy%20and%20safety%20outcomes%20in%20patients%20with%20advanced%20melanoma%20who%20discontinued%20treatment%20with%20nivolumab%20and%20ipilimumab%20because%20of%20adverse%20events%3A%20a%20pooled%20analysis%20of%20randomized%20phase%20II%20and%20III%20trials&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2017.73.2289&volume=35&pages=3807-3814&publication_year=2017&author=Schadendorf%2CD&author=Wolchok%2CJD&author=Hodi%2CFS&author=Chiarion-Sileni%2CV&author=Gonzalez%2CR&author=Rutkowski%2CP&author=Grob%2CJJ&author=Cowey%2CCL&author=Lao%2CCD&author=Chesney%2CJ&author=Robert%2CC&author=Grossmann%2CK&author=McDermott%2CD&author=Walker%2CD&author=Bhore%2CR&author=Larkin%2CJ&author=Postow%2CMA?
• How much revenue does https://doi.org/10.1200%2FJCO.2005.06.205 bring in?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16087944 gross monthly?
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1473965?
• How much does http://scholar.google.com/scholar_lookup?&title=Autoimmunity%20correlates%20with%20tumor%20regression%20in%20patients%20with%20metastatic%20melanoma%20treated%20with%20anti-cytotoxic%20T-lymphocyte%20antigen-4&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.06.205&volume=23&pages=6043-6053&publication_year=2005&author=Attia%2CP&author=Phan%2CGQ&author=Maker%2CAV&author=Robinson%2CMR&author=Quezado%2CMM&author=Yang%2CJC&author=Sherry%2CRM&author=Topalian%2CSL&author=Kammula%2CUS&author=Royal%2CRE&author=Restifo%2CNP&author=Haworth%2CLR&author=Levy%2CC&author=Mavroukakis%2CSA&author=Nichol%2CG&author=Yellin%2CMJ&author=Rosenberg%2CSA generate monthly?
• Financial intake of https://doi.org/10.1158%2F1078-0432.CCR-07-0187
• Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17982122
• How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2147083 generate?
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Prognostic%20factors%20related%20to%20clinical%20response%20in%20patients%20with%20metastatic%20melanoma%20treated%20by%20CTL-associated%20antigen-4%20blockade&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-0187&volume=13&pages=6681-6688&publication_year=2007&author=Downey%2CSG&author=Klapper%2CJA&author=Smith%2CFO&author=Yang%2CJC&author=Sherry%2CRM&author=Royal%2CRE&author=Kammula%2CUS&author=Hughes%2CMS&author=Allen%2CTE&author=Levy%2CCL&author=Yellin%2CM&author=Nichol%2CG&author=White%2CDE&author=Steinberg%2CSM&author=Rosenberg%2CSA
• Profit of https://doi.org/10.1200/jco.2010.28.15_suppl.e13104
• How much income does http://scholar.google.com/scholar_lookup?&title=Association%20of%20adverse%20events%20and%20tumor%20response%20in%20melanoma%20patients%20treated%20with%20tremelimumab&journal=J%20Clin%20Oncol&doi=10.1200%2Fjco.2010.28.15_suppl.e13104&publication_year=2010&author=Pavlov%2CD&author=Marshall%2CMA have?
• Explore the financials of https://doi.org/10.1200%2FJCO.2014.57.4756
• How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25605840?
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Vitiligo-like%20depigmentation%20in%20patients%20with%20stage%20III%E2%80%93IV%20melanoma%20receiving%20immunotherapy%20and%20its%20association%20with%20survival%3A%20a%20systematic%20review%20and%20meta-analysis&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2014.57.4756&volume=33&pages=773-781&publication_year=2015&author=Teulings%2CHE&author=Limpens%2CJ&author=Jansen%2CSN&author=Zwinderman%2CAH&author=Reitsma%2CJB&author=Spuls%2CPI&author=Luiten%2CRM?
• How much does https://doi.org/10.1001%2Fjamadermatol.2015.1916 earn?
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26222619?
• How much income is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061067 earning monthly?
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Pembrolizumab%20cutaneous%20adverse%20events%20and%20their%20association%20with%20disease%20progression&journal=JAMA%20Dermatol&doi=10.1001%2Fjamadermatol.2015.1916&volume=151&pages=1206-1212&publication_year=2015&author=Sanlorenzo%2CM&author=Vujic%2CI&author=Daud%2CA&author=Algazi%2CA&author=Gubens%2CM&author=Luna%2CSA&author=Lin%2CK&author=Quaglino%2CP&author=Rappersberger%2CK&author=Ortiz-Urda%2CS
• Profit of https://citation-needed.springer.com/v2/references/10.1007/s00262-018-2134-z?format=refman&flavour=references
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Katharina%20C.%20K%C3%A4hler income
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Katharina%20C.%20K%C3%A4hler%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Thomas%20K.%20Eigentler gross monthly?
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Thomas%20K.%20Eigentler%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Anja%20Gesierich's revenue stream
• What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Anja%20Gesierich%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Lucie%20Heinzerling?
• What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Lucie%20Heinzerling%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Monthly income for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Carmen%20Loquai
• See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Carmen%20Loquai%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
• How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Friedegund%20Meier make?
• Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Friedegund%20Meier%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
• What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Frank%20Meiss each month?
• What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Frank%20Meiss%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
• How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Claudia%20Pf%C3%B6hler have monthly?
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Claudia%20Pf%C3%B6hler%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• What are the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Max%20Schlaak?
• Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Max%20Schlaak%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Patrick%20Terheyden generate?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Patrick%20Terheyden%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
• Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kai%20M.%20Thoms
• Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kai%20M.%20Thoms%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mirjana%20Ziemer earns monthly
• What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mirjana%20Ziemer%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Lisa%20Zimmer have monthly?
• Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Lisa%20Zimmer%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ralf%20Gutzmer earn?
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ralf%20Gutzmer%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
• What are the total earnings of https://s100.copyright.com/AppDispatchServlet?title=Ipilimumab%20in%20metastatic%20melanoma%20patients%20with%20pre-existing%20autoimmune%20disorders&author=Katharina%20C.%20K%C3%A4hler%20et%20al&contentID=10.1007%2Fs00262-018-2134-z©right=Springer-Verlag%20GmbH%20Germany%2C%20part%20of%20Springer%20Nature&publication=0340-7004&publicationDate=2018-02-27&publisherName=SpringerNature&orderBeanReset=true?
• What are the total earnings of https://crossmark.crossref.org/dialog/?doi=10.1007/s00262-018-2134-z?
• How much does https://citation-needed.springer.com/v2/references/10.1007/s00262-018-2134-z?format=refman&flavour=citation pull in monthly?
• What's the revenue for https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral?
• How much does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research gross monthly?
• How much profit is https://www.springernature.com/gp/products making per month?
• How much does https://www.springernature.com/gp/librarians pull in?
• How much does https://www.springernature.com/gp/societies generate monthly?
• Check the income stats for https://www.springernature.com/gp/partners
• What is the monthly revenue of https://www.springer.com/?
• What's the total monthly financial gain of https://www.nature.com/?
• What's the monthly income of https://www.biomedcentral.com/?
• What are the total earnings of https://www.palgrave.com/?
• Revenue of https://www.apress.com/
• What is the earnings of https://www.springernature.com/gp/legal/ccpa?
• How much revenue does https://www.springernature.com/gp/info/accessibility generate?
• How much income does https://support.springernature.com/en/support/home have?
• https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations's financial summary
• How much profit is https://www.springernature.com/ making per month?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref